A quiet analytical research laboratory at night, racks of glass vials along a dim bench.

Bitter Taste and Palatability

An active nobody will swallow twice is a failed product. Bitterness and off-odors, from berberine, NAC, caffeine, many alkaloids and peptides, restrict formats to capsules and exclude the liquids, shots, gummies and pediatric or veterinary forms that many markets want.

Why actives taste bad

Humans have about 25 bitter taste receptors (TAS2Rs) that detect a broad range of alkaloids, phenolics and hydrophobic peptides at low concentrations. NAC releases sulfurous notes, fish oils oxidize to rancid flavors, and minerals such as zinc and iron add metallic taste. Taste is detected only for dissolved molecules in the mouth, so any approach that keeps the active out of solution for the first minute can mask it. Masking starts there.

Taste-masking approaches

Sweeteners and flavors mask mild bitterness. Stronger cases need physical barriers: polymer coatings on particles, ion exchange resins, cyclodextrin inclusion complexes, lipid matrices and microencapsulation. Each must stay intact in the mouth but release in the stomach or intestine, and coatings must survive chewing or suspension in liquid. Pediatric and veterinary products face the strictest palatability requirements. Masking must also not delay release so much that absorption suffers further downstream.

How palatability is tested

Methods include trained human taste panels, electronic tongue sensors, and in vitro release in simulated saliva over the first minutes. Regulators expect acceptability data for pediatric medicines. For consumer products, repeat-purchase data are the practical test. Release in simulated saliva is the most useful early screen for encapsulated formats, because it directly measures how much active escapes the particle in the time it spends in the mouth. Effective masking should keep that fraction very low.

Key facts

Humans express about 25 functional TAS2R bitter taste receptors (Meyerhof et al. 2010, Chem Senses)
Bitter taste is a major barrier to medication adherence, particularly in children (Mennella et al. 2013, Clin Ther)
Coating, complexation, ion exchange resins and microencapsulation are the principal taste-masking technologies (Sohi et al. 2004, Drug Dev Ind Pharm)
Palatability and acceptability are expected parts of pediatric medicine development in the EU (EMA Guideline on pharmaceutical development of medicines for paediatric use, 2013)

How our delivery technology applies

Taste masking is one of the most reliable wins for encapsulation because the requirement is simple: keep the active out of solution in saliva and release it downstream. A pH-triggered outer layer that stays closed at mouth pH (about 6.5 to 7) and dissolves in gastric acid, with a hydrophobic inner layer, masks bitterness and odor in liquids, shots and chewables. Release is verified in simulated saliva and gastric fluid.

Send us a bitter active for a taste-masking screen.